SLNO — Soleno Therapeutics Inc

Ownership history in MPM BioImpact LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which MPM BioImpact LLC reported a position in Soleno Therapeutics Inc (SLNO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.66% (2025 Q3)
Avg. % of fund
1.19%
First filed
2025 Q2
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 150,000 +100,000 +200.0% 1.66% $10.1M $67.60
2025 Q2 INITIATED 50,000 — — 0.73% $4.2M $83.78
% of Fund (quarterly)    SLNO price (monthly, adj. close)

Other funds also holding SLNO

As of 2025 Q4 — sorted by position size

Ally Bridge Group (NY) LLC 3Y 8.1% GREAT POINT PARTNERS LLC 3Y 7Y 6.0% Buckley Capital Advisors, LLC 4.86% Seven Fleet Capital Management LP 4.58% Commodore Capital LP 3Y 3.7% Artia Global Partners LP 3Y 3.5% Catalio Capital Management, LP 2.95% Vivo Capital, LLC 3Y 7Y 2.68% Brummer Multi-Strategy AB 2.45% KINGDON CAPITAL MANAGEMENT, L.L.C. 3Y 7Y 2.2%
← Back to MPM BioImpact LLC Holdings